R. Koytchev et al., INFLUENCE OF THE CYTOCHROME P4502D6-ASTERISK-4 ALLELE ON THE PHARMACOKINETICS OF CONTROLLED-RELEASE METOPROLOL, European Journal of Clinical Pharmacology, 54(6), 1998, pp. 469-474
Aim: The aim of the present paper was to compare the pharmacokinetics
of metoprolol in homozygous Caucasian volunteers for the wild-type CYP
2D6 allele (CYP2D61/CYP2D6'*1) and heterozygous (CYP2D6*1/CYP2D6*4) C
aucasians. Method's: Thirty-six unrelated healthy male Caucasians were
screened for two of the most frequently occurring mutant alleles (CYP
2D63 and CYP2D6*4) using polymerase chain reaction (PCR). Twenty-four
volunteers with a genotype suggesting a rapid hydroxylator phenotype
were enrolled in a bioequivalence trial and each received in a randomi
zed, cross-over fashion one of the three formulations compared. Each f
ormulation contained 200 mg metoprolol tartrate/(tablet). In each of t
he three periods of the trial, one of the formulations was administere
d under fasting conditions in the morning on 4 consecutive days. Blood
for quantification of metoprolol was drawn immediately before the las
t dose and in selected time intervals thereafter. A sensitive and spec
ific high-performance liquid chromatography (HPLC) method with fluores
cence detection was applied for the quantification of metoprolol. Phar
macokinetic parameters were determined for each subject and statistica
lly compared in two groups of 16 homozygous (CYP2D61/CYP2D6*1) and si
x heterozygous (CYP2D61/CYP2D6*4) volunteers. Results: Significant di
fferences between homozygous and heterozygous individuals were observe
d for all pharmacokinetic parameters. The AUC in the course of one tho
se interval of 24 h (AUC(tau)), minium steady-state concentration (C-m
in(ss)) and average steady-state concentration (C-av(ss)) values for h
eterozygous individuals were more than twice those of individuals. Sig
nificantly higher values for C-max(ss), t(1/2), half-value duration (H
VD) and mean residence time (MRT) were also observed in heterozygous v
olunteers. The higher concentrations of metoprolol in heterozygous ind
ividuals also had pharmacodynamic consequences, namely, greater heart
rate and blood pressure reduction.